|
C9ORF78 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.57904808620424E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47569734210151E-11 |
| Normal-vs-Stage2 |
2.834100E-04 |
| Normal-vs-Stage3 |
1.90866999999484E-05 |
| Normal-vs-Stage4 |
1.685760E-02 |
| Stage1-vs-Stage2 |
8.010200E-01 |
| Stage1-vs-Stage3 |
5.170600E-01 |
| Stage1-vs-Stage4 |
9.114400E-01 |
| Stage2-vs-Stage3 |
4.748800E-01 |
| Stage2-vs-Stage4 |
9.424600E-01 |
| Stage3-vs-Stage4 |
6.326400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.48623344134558E-12 |
| Normal-vs-AfricanAmerican |
4.51330000039718E-07 |
| Normal-vs-Asian |
2.693800E-01 |
| Caucasian-vs-AfricanAmerican |
4.058200E-01 |
| Caucasian-vs-Asian |
9.713200E-01 |
| AfricanAmerican-vs-Asian |
8.479200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.16804352248801E-12 |
| Normal-vs-Female |
1.35590000005514E-06 |
| Male-vs-Female |
5.812000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.48849999992429E-07 |
| Normal-vs-Extreme_Weight |
3.94729804398253E-11 |
| Normal-vs-Obese |
3.90850000000498E-05 |
| Normal-vs-Extreme_Obese |
3.971900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.062600E-01 |
| Normal_Weight-vs-Obese |
3.164200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.227000E-01 |
| Extreme_Weight-vs-Obese |
3.248200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.685200E-01 |
| Obese-vs-Extreme_Obese |
8.980400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.218800E-04 |
| Normal-vs-Age(41-60Yrs) |
7.02960000209529E-08 |
| Normal-vs-Age(61-80Yrs) |
1.74904535299447E-12 |
| Normal-vs-Age(81-100Yrs) |
8.528000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.015580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.064400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.266560E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.272000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.655400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.617190E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.43089999848911E-08 |
| Normal-VS-Type2 PRCC |
4.01909949765411E-10 |
| Normal-VS-KIRP CIMP |
2.884600E-03 |
| Normal-VS-Unclassified PRCC |
8.11289999624876E-08 |
| Type1 PRCC-VS-Type2 PRCC |
2.750100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.918300E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.344000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.658200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.889000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.523400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.10479991611135E-10 |
| Normal-vs-N1 |
5.162500E-04 |
| Normal-vs-N2 |
7.916300E-02 |
| N0-vs-N1 |
7.300200E-01 |
| N0-vs-N2 |
7.093200E-01 |
| N1-vs-N2 |
6.682600E-01 |
|
|
